Fibroblast Growth Factor Receptor 2, Recombinant, Human (Keratinocyte Growth Factor Receptor 2, CD332, FGFR2)
Catalog No : USB-208896
531.05€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Fibroblast Growth Factor Receptor 2, Recombinant, Human (Keratinocyte Growth Factor Receptor 2, CD332, FGFR2) | ||
|---|---|---|---|
| Catalog No | USB-208896 | ||
| Supplier’s Catalog No | 208896 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Insect cells | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 195 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | ~90% (RP-HPLC, SDS-PAGE) | ||
| Form | Supplied as a lyophilized powder. No preservative added. Reconstitute with sterile PBS >100ug/ml. For long term storage add a carrier protein (0.1% HSA or BSA). | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~90% (RP-HPLC, SDS-PAGE) | ||
| Description | Fibroblast Growth Factors (FGFs) comprise a family of at least eighteen structurally related proteins that are involved in a multitude of physiological and pathological cellular processes, including cell growth, differentation, angiogenesis, wound healing and tumorgenesis. The biological activities of the FGFs are mediated by a family if type I transmembrane tyrosine kinases which undergo dimerization and autophosphorylation after ligand binding. Four distinct genes encoding closely related FGF receptors, FGFR-1 to -4 are known. Multiple forms of FGFR-1 to -3 are generated by alternative splicing of the mRNAs. A frequent splicing event involving FGFR-1 and -2 results in receptors containing all three Ig domains, referred to as the alpha isoform, or only IgII and IgIII, referred to as the beta isoform. Only the alpha isoform has been identified for FGFR-3 and FGFR-4. Additional splicing events for FGFR-1 to -3, involving the C-terminal half of the IgIII domain encoded by two mutually exclusive alternative exons, generate FGF receptors with alternative IgIII domains (IIIb and IIIc). A IIIa isoform which is a secreted FGF binding protein containing only the N-terminal half of the IgIII domain plus some intron sequences has also been reported for FGFR-1. Mutations in FGFR-1 to -3 have been found in patients with birth defects involving craniosynostosis. Source: Recombinant protein corresponding to human FGFR2, fused with Xa cleavage site with the Fc part of human IgG1, produced in baculovirus, is a heterodimeric, glycosylated, polypeptide chain, expressed in Insect cells. Molecular Weight: ~195kD Biological Activity: Determined by its ability to inhibit human FGF acidic-dependent proliferation on R1 cells. The ED50 for this effect is typically at 15-30ng/ml. Storage and Stability: Lyophilized powder may be stored at -20°C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.a | ||
Product Details
© 2020 Imugex All Rights Reserved